0

Evaluation of a new ovulatory stimulating agent: clomiphene citrate (clomid)

No Authors Listed, 1968

JAMA, 206(3), 635-636

DOI 10.1001/jama.1968.03150030091021 PMID 5695585 Source

Abstract

Clomiphene citrate, in selected patients, is an effective agent for the treatment of infertility due to anovulation. An adequate laboratory and physical evaluation of each individual patient is essential for proper use of the drug. The major adverse reactions encountered are ovarian enlargements and cysts; in most patients, these conditions regress spontaneously after withdrawal of the drug.

Topics

Infertility > Female Factor > Ovulatory DysfunctionReproductive Endocrinology > Ovulation > Induction
clomiphene citrate ovulation induction, clomid for anovulation treatment, ovarian cysts from clomiphene, ovulation stimulation medication, clomid adverse effects, infertility treatment with clomid, anovulatory infertility pharmacological treatment, clomiphene citrate historical use, ovarian enlargement clomiphene, ovulation induction drugs 1960s, clomid patient selection criteria

Cite this article

No Authors Listed (1968). Evaluation of a new ovulatory stimulating agent: clomiphene citrate (clomid). *JAMA*, *206*(3), 635-636. https://doi.org/10.1001/jama.1968.03150030091021

Keywords

Clomiphene, Female, Humans, Infertility, Ovarian Cysts, Ovarian Diseases, Pregnancy

Related articles